PRINCETON, N.J.--(BUSINESS WIRE)--APCER Pharma Solutions, Inc. continues its global drive to provide comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies. In Q1 2020 APCER scientific and business executives will participate in industry events including: 9th DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies, January 11-13 in Washington, DC RAPS (Regulatory Affair
For more information, please visit
http://www.businesswire.com/news/home/20091208006055/en